Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Topics
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
This Fintech Is Building an AI-Powered Bank on the Cheap -- and Trades for Less Than Book Value
Via The Motley Fool
Topics Artificial Intelligence Bankruptcy Credit Cards
Exposures Artificial Intelligence Financial Intellectual Property
Tickers LC
Acadia Pharmaceuticals (ACAD) Stock Explodes 26% After Patent Court Victory
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Tickers ACAD
The Hidden Mysteries of Wastewater Treatment Pumps
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Advances NV-387 Antiviral Program, Prepares for Multiple Phase II Trials
Via Investor Brand Network
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Tickers NNVC
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q1 Results, Highlights Progress on Ketamine NDA and HOPE Clinic Rollup
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers NRXP
Here's How Many Shares of Pfizer You Should Own to Make $10,000 in Annual Dividend Income
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
Tickers PFE
$7.8 Million in New Financing for Clinic Acquisitions Supporting Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression and PTSD: NRXP
Via Get News
Topics Intellectual Property
Exposures Intellectual Property
Tickers NRXP
CRAI Q1 Earnings Call: Broad-Based Growth, Robust Antitrust Demand, and Steady Guidance
Via StockStory
Topics Intellectual Property
Exposures Intellectual Property
Tickers CRAI
$7.8M Financing Boosts NRx's Expansion with Kadima Institute Acquisition for PTSD and Depression Care: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property
Casper & Americorp Bring $144B Parking Industry On-Chain
Via Stocktwits
Topics Intellectual Property
Exposures Intellectual Property
AquaBounty Technologies Announces First Quarter 2025 Financial Results
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
Tickers AQB
InvestorkNewsBreaks – SKYX Platforms Corp. (NASDAQ: SKYX) Reports Record Q1 Revenue and Expands Plug & Play Footprint
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Tickers HD SKYX
HNO International Chairman & CEO releases ‘The Future is Hydrogen’ Video Interview from the Floor of the NYSE
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property
Tickers HNOI
3 Small-Cap Stocks in the Doghouse
Via StockStory
Topics Intellectual Property
Exposures Intellectual Property
Tickers NYT SATS SXI
Nearshore Software Developers For SaaS Staff Augmentation: Guide Series Launched
Via Press Release Distribution Service
Topics Intellectual Property
Exposures Intellectual Property
MATW Q1 Earnings Call: Missed Revenue Targets as Energy and Memorialization Segments Face Headwinds
Via StockStory
Topics Intellectual Property
Exposures Intellectual Property
Tickers MATW
Sergey Macheret Publishes Groundbreaking Blog on Emerging Hypersonic Plasma Technologies
Via Get News
Topics Intellectual Property
Exposures Intellectual Property
PsychedelicNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Set to Report Q1 Earnings in Wake of HOPE’s Strategic Kadima Agreement
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers NRXP
BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Advances NV-387 Antiviral as Measles and MPox Resurge Globally
Via Investor Brand Network
Topics Intellectual Property
Exposures COVID-19 Intellectual Property Product Safety
Tickers NNVC
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers BEAT BMWYY
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Advances Phase 3 Alzheimer’s Trial and Expands Conference Presence in Q1
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Tickers ANVS BMWYY
InvestorNewsBreaks – SKYX Platforms Corp. (NASDAQ: SKYX) Secures $4 Million Strategic Investment as Part of $15 Million Funding Round
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Tickers SKYX
Genofab Announces Publication Of Groundbreaking Self-Documenting Plasmid Technology In Trends In Biotechnology
Via Press Release Distribution Service
Topics Intellectual Property
Exposures Intellectual Property
Dedepu Launches Next-Gen Portable Diving Gear, Ushering in a Smarter Era of Underwater Exploration
Via 24-7 Press Release
Topics Intellectual Property
Exposures Intellectual Property
1 Hated Stock that Deserves a Second Chance and 2 to Brush Off
Via StockStory
Topics Intellectual Property
Exposures Intellectual Property
Tickers CACI ITW MMI
Pharmaceuticals Stocks Q1 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Tickers JAZZ
Williams-Sonoma Moves A Step Closer To Buying Bankrupt Dormify's IP: Retail Bullish
Via Stocktwits
Topics Bankruptcy Intellectual Property
Exposures Financial Intellectual Property Legal
Tickers VOO VTI WSM
Coalition Launches Bold Initiative to Revive U.S. Sugar Industry Amid Closures and Farming Crisis | Nearly $1 Billion Investment
Via Press Release Distribution Service
Topics Intellectual Property
Exposures Intellectual Property
Plan Signed to Purchase Kadima Neuropsychiatry Institute as Clinical Treatment Model and Leading Investigative Site Addressing Suicidal Depression and PTSD: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Topics Intellectual Property
Exposures Intellectual Property
Tickers NRXP
Plan Signed to Purchase Kadima Neuropsychiatry Institute as Clinical Treatment Model and Leading Investigative Site Addressing Suicidal Depression
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.